ARCHIVES

Surveillance Treatment Option For Low-Risk Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 7 | July 30, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989

NIH Grants: NIH Can’t Award Funds To Schools That Prevent Military Recruiting

September 12, 1997

Letter To The Editor: Prevention Research Requires Rigor And Collaboration.

June 20, 2003

FDA Approves Rituxan For CLL

February 19, 2010

Regions Outlined In CIS Proposal

May 31, 1991